American Academy of Pediatrics

Big Pharma Battles Doctors Over Costly Drug for Infants

Big Pharma Battles Doctors Over Costly Drug for Infants
A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the nation's leading pediatrician's group, which recommends scaling back use of the medicine. The dispute involves new guidelines from the American Academy of Pediatrics, which say medical evidence shows the drug benefits few children other than very young preemies.
origin Author: 
Lindsey Tanner
origin Blog: 

Lead Pediatrics Doc: If 14-Year-Old Boy Has Internet Connection, 'I Guarantee' He's Looking at Porn

 Lead Pediatrics Doc: If 14-Year-Old Boy Has Internet Connection, 'I Guarantee' He's Looking at Porn
It's been linked with violence, cyberbullying, school woes, obesity, lack of sleep and a host of other problems. It's not a major cause of these troubles, but "many parents are clueless" about the profound impact media exposure can have on their children, said Dr. Victor Strasburger, lead author of the new American Academy of Pediatrics policy.
origin Author: 
Lindsey Tanner
origin Blog: